Articles tagged with: GENZ
Genzyme Receives FDA Letter (NASDAQ:GENZ)
Genzyme Corporation has announced that they have received a complete response letter from the Food and Drug Administration about the company’s supplemental New Drug Application for Clolar in patients suffering from acute myeloid leukemia or …
Clolar Gets Cool Reception From FDA and up for Approval (GENZ, VION)
Genzyme Corporation (Nasdaq:GENZ) has a new drug application for their new drug Clofarabine ( Clolar), a leukemia drug that will be used to treat older patients.
The Food and Drug Administration criticized the biotech company’s clinical …
